RXL stock forecast, quote, news & analysis

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG), Elevance Health (NYSE:ELV).

The investment seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the S&P Health Care Select Sector Index. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index includes equity securities of companies from the following GICS industries: health care equipment & supplies, health care providers & services; health care technology; biotechnology; pharmaceuticals; and life sciences tools & services. The fund is non-diversified.

The average market capitalization across the ProShares Ultra Health Care ETF is 89.09B. The market cap for tickers in the group ranges from 9.7B to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is HSIC at 9.7B.

The average weekly price growth across all stocks in the ProShares Ultra Health Care ETF was -11%. For the same ETF, the average monthly price growth was -15%, and the average quarterly price growth was -7%. DXCM experienced the highest price growth at 8%, while MRNA experienced the biggest fall at -21%.

The average weekly volume growth across all stocks in the ProShares Ultra Health Care ETF was 63%. For the same stocks of the ETF, the average monthly volume growth was 160% and the average quarterly volume growth was 133%